image: A byproduct of steel production shows potential for fighting global warming, scientists say. view more
Credit: Dmitry Pichugin
ARTICLE #1 FOR IMMEDIATE RELEASE
"Grandma's penicillin" also may help high blood pressure
Journal of Agricultural and Food Chemistry
Chicken soup, that popular home remedy for the common cold sometimes known as "Grandma's Penicillin," may have a new role alongside medication and other medical measures in fighting high blood pressure, scientists in Japan are reporting. Their research is scheduled for the October 22 issue of ACS' biweekly Journal of Agricultural and Food Chemistry.
Ai Saiga and colleagues cite previous studies indicating that chicken breast contains collagen proteins with effects similar to ACE inhibitors, mainstay medications for treating high blood pressure. But chicken breast contains such small amounts of the proteins that it could not be used to develop food and medical products for high blood pressure. Chicken legs and feet, often discarded as waste products in the U.S. but key soup ingredients elsewhere, appear to be a better source.
In the new study, Saiga and colleagues extracted collagen from chicken legs and tested its ability to act as an ACE inhibitor in the laboratory studies. They identified four different proteins in the collagen mixture with high ACE-inhibitory activity. Given to rats used to model human high blood pressure, the proteins produced a significant and prolonged decrease in blood pressure, the researchers say. — MTS
ARTICLE #1 FOR IMMEDIATE RELEASE
"Angiotensin I-Converting Enzyme-Inhibitory Peptides obtained from Chicken Collagen Hydrolysate"
DOWNLOAD FULL TEXT ARTICLE
http://dx.doi.org/10.1021/jf072669w
CONTACT:
Ai Saiga
Nippon Meat Packers, Inc.
Ibaraki, Japan
Phone: 81-29-847-7815
Fax: 81-29-847-7824
Email: a.egusa@nipponham.co.jp
ARTICLE #2 FOR IMMEDIATE RELEASE
Toward an effective treatment for a major hereditary disease
ACS Chemical Biology
Scientists are reporting a key advance toward developing the first effective drug treatment for spinal muscular atrophy (SMA), a genetic disease that involves motor neuron loss and occurs in 1 out of every 6,000 births. SMA is the leading cause of hereditary infant death in the United States. The study is scheduled for publication online Oct. 8 by ACS Chemical Biology, a monthly journal.
Mark E. Gurney, Jill Jarecki, and colleagues note that SMA is caused by a defective gene, SMN1, which fails to produce sufficient amounts of a key protein, called SMN (survival motor neuron), needed for normal motor neuron development. Scientists have screened more than 550,000 compounds in the search for a new SMA drug. Recent research pointed to a group of compounds called C5-quinazolines that can boost SMN2 activity, a uniquely existing back-up gene for SMN1. In doing so, they showed promise for treating SMA by producing increased amounts of the needed protein.
In the new study, researchers identified exactly how these promising compounds work, a key step in moving forward toward medical use. They found that the substance targets a normal cellular protein, DcpS, involved in mRNA metabolism whose inhibition causes increased SMN expression. The finding could help guide the development of the first effective drugs for treating SMA and also lead to second generation drugs targeting this enzyme, the researchers say. "The results outlined in the paper and carried out in collaboration with Families of SMA, deCODE chemistry & biostructures, Invitrogen Corporation, and Rutgers University represent a new understanding of the physiological mechanisms that can increase SMN expression and will allow us to move forward in advancing potential treatments for it, says Jill Jarecki, Ph.D., Research Director at Families of SMA. — MTS
ARTICLE #2 FOR IMMEDIATE RELEASE
"DcpS as a Therapeutic Target for Spinal Muscular Atrophy"
FOR FULL TEXT: Contact Michael Bernstein, m_bernstein@acs.org, or 202-872-4400.
CONTACT:
Mark E. Gurney, Ph.D.
dCODE Genetics, Inc.
Woodridge, IL
Phone: +1-616-635-0937
Fax: +1-630-783-4909
Email: mark.gurney@decode.com
Jill Jarecki, Ph.D.
Research Director
Families of SMA
P.O. Box 196
Libertyville, IL 60048-0196
Phone: 800-886-1762
Email: jill@fsma.org
Brian Pollok, Ph.D.
Chief Scientific Officer
Invitrogen Corporation
Carlsbad, CA 92008
Phone: 858-849-5375
Fax: 760-930-4865
Email: brian.pollok@invitrogen.com
ARTICLE #3 FOR IMMEDIATE RELEASE
Byproduct of steel shows potential in CO2 sequestration
Industrial & Engineering Chemistry Research
With steelworks around the world emitting huge amounts of carbon dioxide, scientists are reporting that a byproduct of steel production could be used to absorb that greenhouse gas to help control global warming. The study is scheduled for the October 15 issue of ACS' Industrial & Engineering Chemistry Research, a bi-weekly journal.
Professor Mourad Kharoune and colleagues point out that production of one ton of steel releases up to one ton of CO2. With global steel production standing at 1.34 billion tons in 2007, that adds up to a substantial contribution of carbon dioxide. Kharoune suggests a new method to sequester, or capture, carbon dioxide so that it does not contribute to global warming – using steel slags, which are complex mixtures of compounds produced during the separation of the molten steel from impurities.
In the study, Kharoune suggests that electric arc furnace (EAF) and ladle furnace (LF) slag suspensions could be used for greenhouse-gas sequestration. According to the report, the ladle furnace slag suspension's capacity to sequester emissions was 14 times higher than that of the EAF suspension, possibly due to the LF's higher content of a rare mineral called portlandite. — JS
ARTICLE #3 FOR IMMEDIATE RELEASE
"CO2 Sequestration Potential of Steel Slags at Ambient Pressure and Temperature"
DOWNLOAD FULL TEXT ARTICLE
http://dx.doi.org/10.1021/ie701721j
CONTACT:
Mourad Kharoune, Ph.D.
Professor, Industrial Process Engineering
Department of Automated Manufacturing Engineering
École de Technologie Supérieure
1100, rue Notre-Dame Ouest, Montréal (Québec) Canada H3C 1K3
Phone: (514) 396-8640
Fax: (514) 396-8595
Email: mourad.kharoune@etsmtl.ca
ARTICLE #4 FOR IMMEDIATE RELEASE
First evidence that a common pollutant may reduce iodine levels in breast milk
Environmental Science & Technology
Researchers in Texas are reporting the first evidence from human studies that perchlorate, a common pollutant increasingly found in food and water, may interfere with an infant's availability of iodine in breast milk. Iodine deficiency in infants can cause mental retardation and other health problems, the scientists note. The study also provides further evidence that iodine intake in U.S. mothers is low and that perchlorate may play a key role.
In a study scheduled for the November 1 issue of ACS' semi-monthly Environmental Science & Technology, Purnendu Dasgupta and colleagues note that perchlorate occurs naturally in the soil and is also manufactured as a rocket fuel and explosive ingredient. Past studies showed that perchlorate can inhibit iodine uptake. However, scientists did not know its effects on iodine levels in the milk of nursing mothers.
To find out, the researchers collected breast milk samples from 13 breastfeeding mothers and measured their content of iodine, perchlorate, and thiocyanate, another iodine inhibitor found in certain foods. The study showed that if these breast milk samples were fed to infants, 12 of 13 infants would not have an adequate intake of iodine. It also showed that nine of the infants would have ingested perchlorate at a level exceeding those considered safe by the National Academy of Sciences. "Even though the number of subjects was not large, in terms of the number of total samples analyzed, this is the most extensive study on the topic," the researchers say, adding that the low iodine levels are "disconcerting." — MTS
ARTICLE #4 FOR IMMEDIATE RELEASE
"Intake of Iodine and Perchlorate and Excretion in Human Milk"
DOWNLOAD FULL TEXT ARTICLE
http://dx.doi.org/10.1021/es801549w
CONTACT:
Purnendu K. Dasgupta, Ph.D.
The University of Texas at Arlington
Arlington, Texas 76109-0065
Phone: 817-272-3171
Fax: 817-272-3808
Email: Dasgupta@uta.edu
ARTICLE #5 EMBARGOED FOR 9 A.M., EASTERN TIME, Oct. 13, 2008
Freeing protein-based drugs from bacteria's natural traps
Chemical & Engineering News
In a finding that could speed the development of new protein-based drugs for fighting diabetes, hepatitis, and other diseases, researchers are reporting progress toward preventing or destroying an unusual structure that reduces the production yield of bioengineered drugs. The article is scheduled for the Oct. 13 issue of Chemical & Engineering News, ACS' weekly newsmagazine.
In the article, C&EN Associate Editor Jyllian Kemsley notes that genetically-engineered E. coli bacteria are increasingly used to produce protein-based drugs for a variety of diseases. However, these proteins are often not usable because they become trapped in large, insoluble clumps called "inclusion bodies." Current methods to extract proteins trapped in these clumps involve breaking down the clumps chemically and refolding the proteins, a process that is inefficient and sometimes destroys the desired protein.
In the article, Kemsley describes new research insights into the structure and formation of these unusual clumps that could lead to their prevention. Scientists, for instance, have discovered evidence that inclusion bodies form due to interactions between molecular structures called beta-sheets and that clumping could be prevented by preventing beta-sheet interactions.
ARTICLE #5 EMBARGOED FOR 9 A.M., EASTERN TIME, Oct. 13, 2008
"Protein Aggregates Probed"
This story will be available on Oct. 13 at
http://pubs.acs.org/cen/science/86/8641sci1.html
FOR ADVANCE INFORMATION, CONTACT:
Michael Bernstein
ACS News Service
Phone: 202-872-6042
Fax: 202-872-4370
Email: m_bernstein@acs.org
Journalists' Resources
Have a Ball with National Chemistry Week Oct. 19 - 25
Activities will be held in communities around the United States Oct. 19-25 during National Chemistry Week, the American Chemical Society's annual showcase of chemistry's central role in everyday life. The theme will be "Having a Ball with Chemistry," emphasizing the role chemistry plays in fitness and athletics. Thousands of students will learn about chemistry's role in providing new materials and technology to improve athletic equipment and performance, and the importance of nutrition and maintaining an active lifestyle. For more information, including the location of local NCW events, please visit http://www.chemistryweek.org.
Press releases, chat room sessions, and more from ACS' 236th National Meeting
www.eurekalert.org/acsmeet.php.
http://www.ustream.tv/channel/acslive.
ACS Press Releases
General science press releases on a variety of chemistry-related topics. http://portal.acs.org/portal/acs/corg/content?_nfpb=true&_pageLabel=PP_ARTICLEMAIN&node_id=222&content_id=CTP_006740&use_sec=true&sec_url_var=region1
General Chemistry Glossary
http://antoine.frostburg.edu/chem/senese/101/glossary.shtml
Podcasts
Global Challenges/Chemistry Solutions
Don't miss this special series of ACS podcasts on some of the 21st Century's most daunting challenges, and how cutting-edge research in chemistry matters in the quest for solutions. This sweeping panorama of challenges includes topics such as providing a hungry, thirsty world with ample supplies of safe food and clean water; developing alternatives to petroleum to fuel the global economy; preserving the environment and assuring a sustainable future for our children; and improving human health. An ongoing saga of chemistry for life — chemistry that truly matters— Global Challenges debuted June 25 and will have new episodes through December. Subscribe at iTunes [itpc://feeds.feedburner.com/GlobalChallenges] or listen and access other resources at the ACS web site www.acs.org/GlobalChallenges.
Bytesize Science, a new podcast for young listeners
Bytesize Science is a science podcast for kids of all ages that aims to entertain as much as it educates.
Subscribe to Bytesize Science using iTunes [http://ax.phobos.apple.com.edgesuite.net/WebObjects/MZStore.woa/wa/browserRedirect?url=itms%253A%252F%252Fax.phobos.apple.com.edgesuite.net%252FWebObjects%252FMZStore.woa%252Fwa%252FviewPodcast%253Fid%253D266670954]
No iTunes? No problem. Listen to the latest episodes of Bytesize Science [http://feeds.feedburner.com/BytesizeScience] in your web browser.
Science Elements: ACS Science News Podcast
The ACS Office of Communications is podcasting PressPac contents in order to make cutting-edge scientific discoveries from ACS journals available to a broad public audience at no charge.
PressPac information is intended for your personal use in news gathering and reporting and should not be distributed to others. Anyone using advance PressPac information for stocks or securities dealing may be guilty of insider trading under the federal Securities Exchange Act of 1934.
The American Chemical Society — the world's largest scientific society — is a nonprofit organization chartered by the U.S. Congress and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.